Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 25 February 1994:
Vol. 263. no. 5150, p. 1076
DOI: 10.1126/science.263.5150.1076-b
Prev | Table of Contents | Next

Articles

Corrections and Clarifications

The report "Cure of xenografted human carcinomas by BR96-Doxorubicin immunoconjugates" by P. A. Trail et al. (9 July, p. 212), inadvertently omitted a reference to unpublished information about the specifics of the chemical synthesis of BR96-DOX conjugates. This information has now been published [D. Willner et al., Bioconjug. Chem. 4, 521 (1993)].

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)